Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 29 09:32AM ET
Dollar change
Percentage change
IndexRUT P/E34.47 EPS (ttm)0.04 Insider Own11.30% Shs Outstand72.95M Perf Week0.00%
Market Cap102.86M Forward P/E9.72 EPS next Y0.14 Insider Trans0.79% Shs Float64.71M Perf Month-5.37%
Income10.62M PEG1.38 EPS next Q-0.03 Inst Own13.41% Short Float / Ratio9.21% / 13.74 Perf Quarter-26.56%
Sales63.62M P/S1.62 EPS this Y133.87% Inst Trans-5.61% Short Interest5.96M Perf Half Y-32.54%
Book/sh0.52 P/B2.69 EPS next Y38.10% ROA14.72% Target Price13.00 Perf Year27.03%
Cash/sh0.56 P/C2.51 EPS next 5Y25.00% ROE79.42% 52W Range1.07 - 3.55 Perf YTD2.92%
Dividend- P/FCF- EPS past 5Y45.43% ROI24.83% 52W High-60.28% Beta1.13
Dividend %- Quick Ratio1.18 Sales past 5Y24.47% Gross Margin74.03% 52W Low31.78% ATR0.09
Employees197 Current Ratio1.67 Sales Q/Q-27.06% Oper. Margin21.34% RSI (14)45.97 Volatility4.24% 7.03%
OptionableYes Debt/Eq0.68 EPS Q/Q40.08% Profit Margin16.69% Rel Volume0.35 Prev Close1.36
ShortableYes LT Debt/Eq0.12 EarningsNov 06 BMO Payout- Avg Volume433.77K Price1.41
Recom1.00 SMA20-3.75% SMA50-7.57% SMA200-27.12% Volume8,381 Change3.68%
Date Action Analyst Rating Change Price Target Change
Jun-08-20Reiterated H.C. Wainwright Buy $3 → $11
Apr-17-17Reiterated Rodman & Renshaw Buy $4 → $5
Apr-04-16Initiated Rodman & Renshaw Buy $3.50
Apr-23-15Upgrade Jefferies Hold → Buy $2 → $2.60
Nov-12-14Reiterated R. F. Lafferty Buy $8 → $5
Jan-24-14Initiated R. F. Lafferty Buy $8
May-02-12Reiterated Oppenheimer Outperform $9 → $11
May-02-12Downgrade Canaccord Genuity Buy → Hold $8 → $8
Apr-30-12Downgrade Auriga Buy → Hold $8 → $8
Oct-13-11Initiated Morgan Joseph Hold
Nov-07-23 09:04AM
Nov-06-23 08:04AM
Oct-30-23 06:50AM
06:50AM Loading…
Oct-09-23 06:50AM
Sep-12-23 06:50AM
Sep-06-23 06:50AM
Aug-08-23 09:14AM
Aug-07-23 06:50AM
Aug-01-23 06:50AM
Jul-31-23 06:50AM
Jun-08-23 06:50AM
May-30-23 11:00AM
06:50AM Loading…
May-23-23 06:50AM
May-18-23 06:50AM
May-11-23 07:59AM
May-10-23 04:16PM
May-08-23 02:32AM
May-05-23 07:26AM
May-04-23 06:50AM
Apr-27-23 06:50AM
Mar-21-23 06:50AM
Mar-13-23 06:50AM
Feb-28-23 08:52PM
06:30AM Loading…
Feb-27-23 06:30AM
Feb-24-23 09:15AM
Feb-21-23 06:55AM
Jan-06-23 07:04AM
Jan-03-23 06:50AM
Dec-21-22 04:30PM
Dec-05-22 06:50AM
Dec-04-22 09:00AM
Nov-30-22 02:59PM
Nov-15-22 04:46AM
Nov-14-22 06:50AM
Nov-07-22 06:50AM
Sep-21-22 08:00AM
Sep-12-22 12:40PM
Sep-06-22 06:50AM
Aug-16-22 05:55AM
Aug-15-22 06:50AM
Aug-08-22 06:50AM
Jun-30-22 04:30PM
Jun-14-22 09:23AM
May-26-22 04:30PM
May-17-22 06:13AM
May-16-22 06:50AM
May-09-22 06:50AM
Apr-07-22 10:05AM
Apr-05-22 07:40AM
Apr-04-22 06:50AM
Apr-01-22 06:22AM
Mar-31-22 06:50AM
Mar-24-22 06:50AM
Mar-18-22 09:54AM
Mar-07-22 07:00AM
Feb-28-22 04:45AM
Feb-24-22 07:27AM
Feb-03-22 06:50AM
Dec-22-21 06:50AM
Nov-15-21 10:18AM
Nov-08-21 06:50AM
Oct-15-21 08:37AM
Oct-11-21 06:50AM
Aug-26-21 06:50AM
Aug-18-21 06:06AM
Aug-16-21 06:50AM
Aug-13-21 06:50AM
Aug-09-21 07:15AM
Aug-02-21 06:50AM
Jun-30-21 09:56AM
Jun-28-21 06:50AM
Jun-07-21 10:18PM
Jun-05-21 08:16PM
Jun-03-21 09:28AM
Jun-02-21 12:10PM
May-25-21 06:50AM
May-14-21 06:50AM
May-07-21 10:30AM
Apr-29-21 05:45AM
Apr-28-21 03:25PM
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Carmiel, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bashan DrorPRESIDENT AND CEOOct 19Buy1.4064,51690,484132,516Oct 20 06:50 AM
Schwartz AharonDirectorJan 03Buy1.42110,000155,815174,000Jan 05 05:08 PM